Neuropsychopharmacology
- AI-based analysis of social media language predicts addiction treatment dropout at 90 days1 year ago
- Neural complexity EEG biomarkers of rapid and post-rapid ketamine effects in late-life treatment-resistant depression: a randomized control trial1 year ago
- Transdiagnostic evaluation of epigenetic age acceleration and burden of psychiatric disorders1 year ago
- LPA1 receptors in the lateral habenula regulate negative affective states associated with alcohol withdrawal1 year ago
- Robust aversive effects of trace amine-associated receptor 1 activation in mice1 year ago
- Predictors of placebo response in three large clinical trials of the V1a receptor antagonist balovaptan in autism spectrum disorder1 year ago
- The effects of D-Cycloserine on corticospinal excitability after repeated spaced intermittent theta-burst transcranial magnetic stimulation: A randomized controlled trial in healthy individuals1 year ago
Journal of Psychopharmacology
- Projection-specific dopamine neurons in the ventral tegmental area participated in morphine-induced hyperalgesia and anti-nociceptive tolerance in male mice4 years ago
- Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action4 years ago
- Association of the OPRM1 A118G polymorphism and Pavlovian-to-instrumental transfer: Clinical relevance for alcohol dependence4 years ago
- Efficacy of onabotulinumtoxinA in the treatment of unipolar major depression: Systematic review, meta-analysis and meta-regression analyses of double-blind randomised controlled trials4 years ago
- Methylphenidate reduces orienting bias in healthy individuals4 years ago
- Contrasting effects of the α7 nicotinic receptor antagonist methyllycaconitine in different rat models of heroin reinstatement4 years ago
- Two randomized, double-blind, placebo-controlled trials and one open-label, long-term trial of brexpiprazole for the acute treatment of bipolar mania4 years ago
European Neuropsychopharmacology
- Results of the COVID-19 MEntal health inTernational for the General population (COMET-G) study.3 years ago
- A GWAS top hit for circulating leptin is associated with weight gain but not with leptin protein levels in lithium-augmented patients with major depression3 years ago
- Rapid response to selective serotonin reuptake inhibitors in post-COVID depression3 years ago
- Monitoring inflammation in psychiatry: Caveats and advice3 years ago
- Depression and inflammation: Correlation between changes in inflammatory markers with antidepressant response and long-term prognosis3 years ago
- Glutamate modulators and beyond: A neuroscience revolution in the making3 years ago
- Cannabis use and psychosis susceptibility: A call to action3 years ago